Letter
Benefit of different concentrations of intralesional triamcinolone acetonide in alopecia areata: An intrasubject pilot study

https://doi.org/10.1016/j.jaad.2015.04.049Get rights and content

First page preview

First page preview
Click to open first page preview

References (5)

There are more references available in the full text version of this article.

Cited by (41)

View all citing articles on Scopus

Funding sources: None.

Disclosure: Dr Shapiro has received honoraria for serving as a consultant and speaker for Merck, Johnson & Johnson, and Applied Biology. Drs Shapiro and McElwee are also the founders and shareholders of Replicel Life Sciences Inc. Drs Chu, Al Jasser, Alharbi, and Abahussein have no conflicts of interest to declare.

View full text